Query Trace: Rare diseases[orginal query] |
---|
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Maria D Karaceper, Pranesh Chakraborty, Doug Coyle, Kumanan Wilson, Jonathan B Kronick, Steven Hawken, Christine Davies, Marni Brownell, Linda Dodds, Annette Feigenbaum, Deshayne B Fell, Scott D Grosse, Astrid Guttmann, Anne-Marie Laberge, Aizeddin Mhanni, Fiona A Miller, John J Mitchell, Meranda Nakhla, Chitra Prasad, Cheryl Rockman-Greenberg, Rebecca Sparkes, Brenda J Wilson, Beth K Potter, and Orphanet journal of rare diseases 2016 Feb 1112 |
Public Health and Rare Diseases: Oxymoron No More. Rodolfo Valdez, Lijing Ouyang, and Julie Bolen Preventing chronic disease 2016 Jan 13E05 |
Utilizing population controls in rare-variant case-parent association tests. Yu Jiang, Glen A Satten, Yujun Han, Michael P Epstein, Erin L Heinzen, David B Goldstein, and Andrew S Allen Am. J. Hum. Genet. 2014 Jun 5. 94(6) 845-53 |
The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia. Scott D Grosse, Sheree L Boulet, Althea M Grant, Mary M Hulihan, and Marie E Faughnan Genet. Med. 2014 Jan 16(1) 33-9 |
A permutation procedure to correct for confounders in case-control studies, including tests of rare variation. Michael P Epstein, Richard Duncan, Yunxuan Jiang, Karen N Conneely, Andrew S Allen, and Glen A Satten Am. J. Hum. Genet. 2012 Aug 10. 91(2) 215-23 |
A public health framework for rare blood disorders. Scott D Grosse, Andra H James, Michele A Lloyd-Puryear, and Hani K Atrash Am J Prev Med 2011 Dec 41(6 Suppl 4) S319-23 |
Cancer Nanotechnology
Hace 12 horas
No hay comentarios:
Publicar un comentario